🇺🇸 US Stock Screener ← Switch market ⚡ HerAI
Financial distress indicators · updated 2026-10-08

GlucoTrack, Inc. — financial distress indicators

GCTK — open full stock page →
HealthcareMedical Devices Mkt cap $886.21KStatements as of Mar 2026 Flows: FY Dec 2025
70VERY WEAK
Distress score / 100
Statistical model output from public data — not an allegation of insolvency or default. Methodology

Financial-health summary

GlucoTrack, Inc.'s reported numbers place it in the 'Very weak' financial-health band (distress score 70/100). The main indicators are liabilities exceed assets (negative equity), cash runway under 12 months and losses in each of the last 3 years. In its favour: revenue still growing (+378% yoy).

—
Current ratio
—
Interest cover
—
Debt / EBITDA
3 mo
Cash runway
—
Ohlson 1-yr PD
—
Merton 1-yr PD
$3.93M
Cash & ST investments
-
Total debt
-99%
From 52-week high

Stress by dimension

Share price — last 12 months

Indicators behind the score

Each red flag shows the evidence from the company’s own filings and the financial or legal principle behind it. Points add to the 0–100 score.

Liabilities exceed assets (negative equity)+18
Solvency

Total liabilities are 1.20× total assets.

Balance-sheet insolvency test: debts exceeding the fair value of assets is the statutory definition of 'insolvent' in 11 U.S.C. §101(32).

Cash runway under 12 months+15
Liquidity

At the current free-cash-flow burn, cash covers ~3 months.

Going-concern standard: management must assess ability to continue for 12 months (ASC 205-40). Runway below that horizon forces dilution, asset sales or default.

Losses in each of the last 3 years+12
Profitability

Net income negative in 3 of 3 fiscal years.

Persistent losses erode equity and the capacity to absorb shocks.

Operations consume cash+10
Cash Flow

Operating cash flow negative in 3 of the last 3 years.

A business that cannot fund itself from operations depends on external capital to survive.

Share price down >80% from 52-week high+10
Market Signal

Price is -99% from its 52-week high.

Equity markets price distress early; collapses of this size usually reflect fear of wipe-out in a restructuring.

Operating-margin collapse+5
Profitability

Operating margin fell from 1794% to 1686% in two years.

Sharp margin compression signals loss of pricing power or cost control.

Revenue vs net income

Cash generation

Debt vs cash vs equity

✅ Mitigating factors

  • Revenue still growing (+378% YoY).

Frequently asked questions

What do GlucoTrack, Inc.'s financial-health indicators show?

As of 2026-10-08, GlucoTrack, Inc.'s public financial data places it in the 'Very weak' band with a distress score of 70/100, driven by liabilities exceed assets (negative equity), cash runway under 12 months and losses in each of the last 3 years. This is a statistical screen of reported numbers — it does not mean the company is insolvent, has defaulted or will enter insolvency proceedings.

What is GlucoTrack, Inc.'s financial distress score?

70/100 ('Very weak').

What works in GlucoTrack, Inc.'s favour?

Revenue still growing (+378% YoY).

How are shareholders treated if a company enters insolvency?

In a Chapter 11 reorganisation the absolute priority rule pays secured lenders, then unsecured creditors, before shareholders — so existing shares are usually cancelled or heavily diluted. In Chapter 7 the company is liquidated and shareholders rarely recover anything.

Other Healthcare & MedTech companies with distress indicators

All Healthcare & MedTech companies with distress indicators →

Methodology

Score = capped sum of rule-based red flags across seven dimensions (liquidity, solvency, profitability, cash flow, sales trend, market signal, news). Ohlson O-score (1980) gives an accounting-based 1-year failure probability; Merton distance-to-default (Bharath & Shumway 2008) gives a market-implied probability. Financial institutions use a capital-based rule set. Recalculated every trading day from the latest filings, prices and news.

Not a prediction of default or insolvency. This page summarises statistical risk indicators from public data. It does not allege insolvency, default or wrongdoing, and the company may have resources or plans not reflected here (undrawn credit lines, asset sales, parent support, recent capital raises). Verify with the company’s filings (SEC 10-K/10-Q). Not investment or legal advice.